USPSTF recommends that women aged 50 to 75 and at average risk for breast cancer undergo mammography screening every 2 years (3) and recommends against screening average-risk men with the prostate-specific antigen (PSA) test (during the 2012–2014 timeframe relevant to this study) (1). The gene discussed is KLK3; the disease is breast carcinoma.